COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, cilt.22, sa.8, ss.577-581, 2019 (SCI-Expanded)
Aim and Objective: Ischemia modified albumin (IMA) is a biomarker that has been introduced recently for use in the evaluation of oxidative stress. The aim of this study was to measure the ischemia modified albumin serum levels in pediatric patients with diabetic ketoacidosis (DKA) during acidosis and after the patient recovered from acidosis and to compare these with the control group.